According to Demis Hassabis on Twitter, DeepMind has launched AlphaGenome, a new AI-powered DNA sequence model now accessible through the AlphaGenome API. This model enables researchers to predict genome function with high accuracy, accelerating biological discovery and facilitating the development of innovative treatments. The integration of AlphaGenome into scientific workflows is expected to enhance genomics-driven drug discovery, streamline disease research, and create new business opportunities in AI-powered healthcare and precision medicine (source: @demishassabis, June 25, 2025).

According to Google DeepMind, the AlphaGenome AI model enables scientists to rapidly predict the impact of genetic changes, revolutionizing DNA analysis and hypothesis generation in genomics research (source: Google DeepMind, June 25, 2025). This breakthrough assists researchers in understanding the functional consequences of genetic variants, potentially expediting new drug discovery and personalized medicine applications. The model's ability to process vast genomic datasets efficiently opens significant business opportunities for biotech firms, pharmaceutical companies, and healthcare providers seeking AI-powered genomic interpretation tools.